FIDELITY: Finerenone Cuts CV Risk in T2D Across CKD Spectrum ...Middle East

Medscape - News
Importantly, the study saw few cases of hyperkalemia associated with the drug, suggesting it avoids a major problem associated with spironolactone and eplerenone. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FIDELITY: Finerenone Cuts CV Risk in T2D Across CKD Spectrum )

Apple Storegoogle play

Also on site :

Most viewed in News